There is no specific therapy for aspirin resistance.
阿司匹林抵抗尚无特异性治疗方法。
Results Of 302 cases, 58 cases developed aspirin resistance (19.2%).
结果302例患者中58例存在阿司匹林抵抗，占19.2%。
Is platelet function testing for aspirin resistance reasonable to do?
针对阿司匹林抵抗的血小板功能检测合理吗？
Clinical trials have shown that laboratory aspirin resistance is correlated with vascular events.
多项临床试验证实，实验室阿司匹林抵抗和临床血管事件相关。
Ticlopidine can dramatically reduce the expression of PAC-1 in CHD patients with aspirin resistance ( P< 0 001).
抵克力特可显著降低存在阿斯匹林抵抗现象的病人PAC - 1的表达（P< 0 0 0 1）。
ABSTRACT: aspirin is an important antithrombotic agent. However, its clinical benefit is impaired by aspirin resistance.
摘要：阿司匹林是抗血栓治疗的重要药物，阿司匹林抵抗是影响其疗效的常见原因。
Objective To explore the clinical signi fi cance of CAP changes and the management of aspirin resistance in CHD patients.
目的探讨冠心病患者循环活化血小板（CAP）的变化及对阿斯匹林抵抗的处理。
Objective: To study the effect of combine treatment on aspirin resistance (ar) in patients with acute coronary syndrome (ACS).
目的：探讨联合治疗对冠脉综合征(ACS)患者阿司匹林抵抗(AR)的疗效。
Objective To explore the effect of clopidogrel bisulfate on aspirin resistance (AR) in patients with ischemic cerebrovascular disease.
目的观察氯吡格雷对缺血性脑血管病患者阿司匹林抵抗（AR）的影响。
Conclusion Tongxinluo may reduce platelet aggregation rate and produce certain therapeutic effect for the patients with aspirin resistance.
结论通心络可以降低血小板聚集率，对于阿司匹林抵抗患者，选用通心络治疗可以取得一定的疗效。
So far, however, still can not explain all of the same mechanism of aspirin resistance, and many have to await its findings are contradictory.
但到目前为止，仍无法用同一机制解释所有的阿司匹林抵抗，并且，很多研究所得出的结果是矛盾的。
Expect to use the same mechanism to explain all the phenomena of aspirin resistance is not feasible, it should be for different groups to do more research.
期望用同一机制解释所有的阿司匹林抵抗现象是不可行的，应当针对不同群体做更多的研究工作。
Aspirin resistance was more common among women, older patients, patients with renal insufficiency, those with low hemoglobin levels and those on relatively low doses of aspirin, the researchers note.
研究者指出，阿司匹林抵抗较常见于女性、老年人、肾功能不全、低血红蛋白和阿司匹林剂量偏小的患者。
However, they found no link between the use of enteric-coated aspirin and resistance to the drug; past studies, they note, have had "conflicting" findings on this point.
但是，他们发现服用肠溶阿司匹林和阿司匹林抵抗之间没有关系，而以前有些研究却认为两者存在相关性。
Aspirin therapy may influence cardiovascular disease and cancer through its effect on common pathogenic pathways, such as inflammation, insulin resistance, oxidative stress, and Cox enzyme activity.
阿斯匹林治疗可能通过普通病原性途径，如炎症、胰岛素抵抗、氧化应激、环氧化酶活性来影响心血管疾病和癌症。
Conclusion Aspirin can change chronic inflammation in elderly patients with insulin resistance, and lower CRP, and improve insulin sensitivity.
结论阿司匹林可改变老年胰岛素抵抗患者慢性炎症反应，从而降低CRP水平，改善胰岛素抵抗。
Conclusion Aspirin can change chronic inflammation in elderly patients with insulin resistance, and lower CRP, and improve insulin sensitivity.
结论阿司匹林可改变老年胰岛素抵抗患者慢性炎症反应，从而降低CRP水平，改善胰岛素抵抗。
应用推荐